Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yanwei Zhang

Showing results (261-270 of 340) with videos related to

Pageof 34
Sort By:
Frontiers in Genetics|September 24, 2021
ctDNA-Profiling-Based UBL Biological Process Mutation Status as a Predictor of Atezolizumab Response Among <i>TP53</i>-Negative NSCLC PatientsJun Lu, Yanwei Zhang, Yuqing Lou, et al.
Neuroimage|August 14, 2012
A computational neurodegenerative disease progression score: method and results with the Alzheimer's disease Neuroimaging Initiative cohortBruno M Jedynak, Andrew Lang, Bo Liu, et al.
Clinical Lung Cancer|August 5, 2020
EGFR Tyrosine Kinase Inhibitor (TKI) Combined With Concurrent or Sequential Chemotherapy for Patients With Advanced Lung Cancer and Gradual Progression After First-Line EGFR-TKI Therapy: A Randomized Controlled StudyQing Chang, Jianlin Xu, Huiping Qiang, et al.
Molecular Breeding : New Strategies in Plant Improvement|June 13, 2023
Genetic dissection of seed appearance quality using recombinant inbred lines in soybeanQuan Hu, Yanwei Zhang, Ruirui Ma, et al.
Thoracic Cancer|September 2, 2022
Different clinical characteristics and survival between surgically resected pure and combined small cell lung cancerYujing Li, Yanan Wang, Wensheng Zhou, et al.
Environment International|February 5, 2019
Associations of multiple plasma metals with the risk of ischemic stroke: A case-control studyYing Wen, Suli Huang, Yanwei Zhang, et al.
Lung Cancer (Amsterdam, Netherlands)|September 18, 2022
Safety and efficacy of anlotinib in combination with standard chemotherapy as first-line treatment for extensive-stage small cell lung cancer: A multi-center, prospective study (ACTION-2)Wei Zhang, Pengbo Deng, Tiandong Kong, et al.
Chinese Journal of Cancer Research = Chung-Kuo Yen Cheng Yen Chiu|March 31, 2022
Equivalent efficacy assessment of QL1101 and bevacizumab in nonsquamous non-small cell lung cancer patients: A two-year follow-up data updateJun Lu, Tianqing Chu, Hongyu Liu, et al.
Plos One|October 25, 2016
Identification of Blood Let-7e-5p as a Biomarker for Ischemic StrokeSuli Huang, Ziquan Lv, Yi Guo, et al.
NPJ Precision Oncology|February 27, 2024
Multimodal fusion of liquid biopsy and CT enhances differential diagnosis of early-stage lung adenocarcinomaYanwei Zhang, Beibei Sun, Yinghong Yu, et al.
Pageof 34

Showing results (261-270 of 340) with videos related to

Sort By:
Pageof 34
Frontiers in Genetics|September 24, 2021
ctDNA-Profiling-Based UBL Biological Process Mutation Status as a Predictor of Atezolizumab Response Among <i>TP53</i>-Negative NSCLC PatientsJun Lu, Yanwei Zhang, Yuqing Lou, et al.
Neuroimage|August 14, 2012
A computational neurodegenerative disease progression score: method and results with the Alzheimer's disease Neuroimaging Initiative cohortBruno M Jedynak, Andrew Lang, Bo Liu, et al.
Clinical Lung Cancer|August 5, 2020
EGFR Tyrosine Kinase Inhibitor (TKI) Combined With Concurrent or Sequential Chemotherapy for Patients With Advanced Lung Cancer and Gradual Progression After First-Line EGFR-TKI Therapy: A Randomized Controlled StudyQing Chang, Jianlin Xu, Huiping Qiang, et al.
Molecular Breeding : New Strategies in Plant Improvement|June 13, 2023
Genetic dissection of seed appearance quality using recombinant inbred lines in soybeanQuan Hu, Yanwei Zhang, Ruirui Ma, et al.
Thoracic Cancer|September 2, 2022
Different clinical characteristics and survival between surgically resected pure and combined small cell lung cancerYujing Li, Yanan Wang, Wensheng Zhou, et al.
Environment International|February 5, 2019
Associations of multiple plasma metals with the risk of ischemic stroke: A case-control studyYing Wen, Suli Huang, Yanwei Zhang, et al.
Lung Cancer (Amsterdam, Netherlands)|September 18, 2022
Safety and efficacy of anlotinib in combination with standard chemotherapy as first-line treatment for extensive-stage small cell lung cancer: A multi-center, prospective study (ACTION-2)Wei Zhang, Pengbo Deng, Tiandong Kong, et al.
Chinese Journal of Cancer Research = Chung-Kuo Yen Cheng Yen Chiu|March 31, 2022
Equivalent efficacy assessment of QL1101 and bevacizumab in nonsquamous non-small cell lung cancer patients: A two-year follow-up data updateJun Lu, Tianqing Chu, Hongyu Liu, et al.
Plos One|October 25, 2016
Identification of Blood Let-7e-5p as a Biomarker for Ischemic StrokeSuli Huang, Ziquan Lv, Yi Guo, et al.
NPJ Precision Oncology|February 27, 2024
Multimodal fusion of liquid biopsy and CT enhances differential diagnosis of early-stage lung adenocarcinomaYanwei Zhang, Beibei Sun, Yinghong Yu, et al.
Pageof 34